Immucell (ICCC) Short-term Investments (2010 - 2020)

Immucell (ICCC) has reported Short-term Investments for 11 consecutive years, with $996495.0 the latest figure, recorded in Q4 2020.

• For the quarter ending Q4 2020, Short-term Investments fell 59.83% year-over-year to $996495.0; the trailing twelve-month figure through Dec 2020 stood at $996495.0 (down 59.83% YoY), and the FY2020 full-year result was $996495.0, down 59.83% from the prior year.
• Short-term Investments retreated to $996495.0 in Q4 2020 per ICCC's latest filing, from $2.0 million in the prior quarter.
• Across five years, Short-term Investments topped out at $8.7 million in Q2 2019 and bottomed at $4117.0 in Q1 2019.
• Historically, Short-term Investments has averaged $3.4 million across 5 years, with a median of $2.5 million in 2019.
• The sharpest annual moves came in 2017 and 2020: Short-term Investments plunged 92.69% in 2017, then surged 11894.68% in 2020.
• Over 5 years, Short-term Investments stood at $5.5 million in 2016, then tumbled by 91.06% to $489582.0 in 2017, then slumped by 91.79% to $40209.0 in 2018, then surged by 6069.65% to $2.5 million in 2019, then slumped by 59.83% to $996495.0 in 2020.
• According to Business Quant data, Short-term Investments over the past three periods registered $996495.0, $2.0 million, and $2.0 million for Q4 2020, Q3 2020, and Q2 2020 respectively.